A recent study by Michael et al. (2021) explores the long-term effects of ataluren on patients’ upper motor and respiratory function. Long-term cumulative treatment outcomes over a median period of 6.3 years on ataluren treatment indicated a delay in the loss of ambulation, a slower decline in forced vital capacity (FVC) and upper limb motor function even after loss of ambulation.
The Vitalograph Alpha was used to measure forced vital capacity in this study.
Read the full report: https://doi.org/10.1186/s12891-021-04700-z
Learn how our custom solutions and personalized approach meet a wide range of respiratory clinical study needs.